Hyperkalemia Treatment in CKD - BC Kidney Days 2020

Dr. Biff Palmer of the University of Texas Southwestern Medical Center discusses the evolving treatments for hyperkalemia in patients with chronic kidney disease (CKD). He begins by talking about the distribution of potassium throughout the body, and how it is processed in the kidneys.

0:13:35 – How Potassium Homeostasis in Altered in CKD
He discusses evidence between kidneys and plasma levels of potassium.
0:17:17 – Management of Hyperkalemia
He discusses medications, diet, and diuretics in the context of hyperkalemia.
0:24:30 – Potassium Binding Agents
Dr. Palmer highlights data on sodium polystyrene sulfonate, noting that it is poorly tolerated and not particularly effective. Instead, he points to new data in support of Patiromer and sodium zirconium cyclosilicate in treating hyperkalemia.
0:32:10 – Summary and Q&A
Dr. Palmer summarizes his key points and takes questions from the audience.
#KidneyCare #ChronicKidneyDisease #Hyperkalemia